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Abstract:  
Wastewater analysis has been taken up with enthusiasm in the illicit drugs field. Through a critical 
social science lens, we consider claims to what these ‘promising’ methods might afford in the 
context of drug epidemiology and policy, recognising that all methods have social effects in their 
specific contexts of use. We outline several ethico-political issues, highlighting how methods can 
have different effects as they move from one discipline (environmental science or analytic 
chemistry) and into another (illicit drugs). Translated into the drugs field, wastewater analysis 
problematically shifts the focus of drug policy from harm reduction to drug use prevalence and 
entrenches stigma. Without comprehensive information about the social and contextual aspects of 
drug harms, effective drug policy is not possible. 
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A ‘promising tool’? A critical review of the social and ethico-political effects of wastewater analysis 
in the context of illicit drug epidemiology and drug policy 
The development of wastewater analysis as a new method is arguably precipitating one of the most 
significant shifts in illicit drug epidemiology in decades. Also called ‘sewage epidemiology’ [1, 2] or 
‘wastewater-based epidemiology’ [3, 4], these methods have quickly generated worldwide interest 
in the illicit drugs field given their potential to provide near “real-time data on geographical and 
temporal trends” in illicit drug consumption [3, 4]. Wastewater analysis is increasingly regarded as 
“an important adjunct to established drug monitoring tools” [4], complementing methods such as 
self-report population or household surveys and analysis of crime statistics and drug seizure data. 
Unlike established epidemiological methods, wastewater analysis is deemed “non-invasive” [3], “not 
subject to the biases associated with self-report data” and able to “better identify the true spectrum 
of drugs being consumed” by a community [4-7] while “preserving the anonymity of the individuals 
involved” [8]. While self-report survey methods are often expensive, take time to administer and 
tend to focus on metropolitan centres [2, 4, 5, 7], wastewater analysis is said to offer “prompt 
identification of changes in trends and habits” [2]. Given that drug use is an illicit and largely hidden 
practice it has also been suggested that wastewater analysis may provide more “realistic” and 
“objective” evidence [7] because “self-reporting of socially censured behaviour is likely to be 
unreliable” [6]. Through the lens of critical social science, in this review we consider claims to what 
wastewater analysis methods might afford as they are rapidly taken up in the context of illicit drug 
epidemiology and drug policy. In doing so, we situate current discussions regarding wastewater 
analysis within a body of literature which has illuminated the need for cross-methodological 
dialogue between social science and epidemiology if drug-related harms are to be understood and 
ameliorated [9, 10], recognising that all methods have social and ethico-political effects in their 
specific contexts of use [10-14]. 
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Wastewater analysis was originally used by environmental scientists for the purposes of monitoring 
the potential ecological risks of excreted pharmaceutical drugs and personal-care products in 
aquatic environments [15-17]. Following speculation that this method might also be used to monitor 
illicit drug use [16], wastewater analysis approaches have subsequently been taken up and adapted 
purportedly to help estimate population-level consumption of illicit drugs. Early studies 
experimented with this approach by measuring human metabolic residue of illicit drugs in surface 
water and wastewater entering sewage treatment plants [6-8, 18, 19] (with the latter sampling 
method recommended for population studies [2]). Since its first experimental application in Italy in 
the mid-2000s [6], this approach has been used in numerous studies and integrated into drug 
monitoring systems around the world including in Australia, China, Canada, South Africa, 
Switzerland, the United States of America, and across Europe and the Nordic states [e.g. 4, 5-7, 20-
34]. Data generated from these studies are also now being used to inform the United Nations Office 
on Drugs and Crime World Drug Report [35]. In a relatively short period of time, wastewater analysis 
has established itself as a “promising tool” [7] in the illicit drugs field. Indeed, it has been said that 
“the advantage of adding another tool to the epidemiological toolkit cannot be overestimated” [4]. 
 
In the context of illicit drug epidemiology, wastewater analysis involves collecting samples of raw 
wastewater which are then analysed to measure particular drug metabolic residues. To translate 
these data into evidence that can made useable and relevant in this specific policy context, total 
amounts of drug metabolic residues are converted into “average doses” [4]. To estimate the 
quantity of illicit drugs consumed in a community, expressed as “daily amounts (or daily doses) per 
thousand population”, a back-calculation is performed which takes into account daily flow rates of 
sewage (to obtain the daily sewer load of metabolic residue), the size of the population served by 
the treatment plant, the average excretion rate of each drug target residue and the molecular mass 
of the parent drug/metabolite, and an assumed mean dose [2-4, 36]. The assumed mean dose is the 
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area of greatest uncertainty. The rationale underlying the approach is that the “concentrations of 
the metabolic residues of illicit drugs measured in raw communal wastewater can […] reflect the 
amount of a particular drug that has been used by a population served by a particular sewer 
network” [36].  
 
The development of wastewater analysis as a technology of illicit drug epidemiology brings together 
multiple forms of expertise across disciplines, including between analytic chemists, environmental 
scientists, illicit drug epidemiologists and policy makers. The first multidisciplinary discussions were 
hosted by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in 2007, and 
considered how these newly developing approaches might be taken up in drugs monitoring efforts 
in Europe [2]. More recently, there have been efforts to coordinate and standardise approaches to 
wastewater analysis studies internationally through the establishment of a European network called 
the ‘Sewage analysis CORe group – Europe’ (SCORE) in 2010 [30, 37]. In 2013, the SCORE network 
published a consensus protocol for sampling, analysis and reporting of wastewater analysis studies, 
which has provided a foundation for the first comparative wastewater analysis studies across Europe 
[24, 37, 38]. As well as refining and developing the technical aspects of wastewater analysis 
methods, these discussions have been aimed at ensuring that data produced in different locations 
and by different research teams are comparable and therefore useful for drug monitoring and 
surveillance.  
 
The processes led by the EMCDDA have also sought to raise key ethical and legal questions about 
the use of wastewater analysis in the context of illicit drug epidemiology given the sociopolitical 
sensitivities and possible risks associated with these approaches, including issues of privacy, consent 
and data protection [2]. The EMCDDA has noted that the purpose of wastewater analysis studies 
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ought to be made clear, in particular “whether the findings are to be used in the interests of public 
health or as part of law enforcement or political control measures” [2]. How these data are put to 
use (that is, made useful as evidence [39]) in the specific context of illicit drug policy is key to these 
ethical considerations. Concerns have been raised that data generated through these measures may 
“form the basis for potentially controversial decisions” [2] in drug policy and be easily 
misinterpreted by media if results are not carefully communicated. Sensationalised media reporting 
can perpetuate “stigmatisation and labelling of vulnerable groups, influencing how they are treated 
by society and the state” and may “generate political incentives to ‘get tough’ on drug use and 
crime” [40] contrary to the aims of evidence-based drug policy. 
 
While it has been suggested that using wastewater analysis approaches in the context of illicit drug 
epidemiology “merely capitalises on science’s existing technical capabilities in analytical chemistry” 
[16], the ethical questions raised by the EMCDDA and others [41-43] point to the ways in which 
methodological tools can have different effects as they move from one discipline (environmental 
science or analytic chemistry) and into another (illicit drugs epidemiology) [13]. An established body 
of critical social science literature in the drugs field has demonstrated why it is important to consider 
the specific context in which a method is put to use, the veracity of measures, and the socio-political 
effects of epidemiological approaches [10, 14]. This work has shown how purportedly more accurate 
measures of ‘risk behaviours’ often remain blind to complex relations, power and structural violence 
at work in the social worlds in which harms occur [9, 10]. What a new and ‘promising’ method might 
afford and how it might produce ‘better evidence’ will always relate to its specific implementation 
and policy context. What is required is critical consideration of how the method is used in relation to 
the ‘problem’ it is purportedly addressing. This requires translation work and multidisciplinary 
dialogue beyond engagement with methods experts, to explore how evidence generated through 
these approaches might be made to matter and put to use locally in specific policy contexts. 
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Although wastewater analysis approaches have been taken up with enthusiasm in the illicit drugs 
field, there are several ethico-political issues deserving of critical attention when we consider how 
these methods translate into this arena [13]. Our focus here is not on the technical, chemical or 
methodological uncertainties of wastewater analysis approaches (for these have been documented 
elsewhere, and continue to be the focus of ongoing scientific development: [e.g. 2, 3, 4, 44-47]). 
Rather, we wish to engage with some of the critical questions that arise when considering how 
wastewater analysis approaches are being mobilised specifically for and within drug policy [13]. 
These questions move beyond concerns about technoscientific capabilities or the ‘promise’ of these 
approaches, to focus on the implications of their use in the specific circumstances of illicit drug 
policy.  
 
Illicit drug use remains criminalised in most jurisdictions around the world [48]. However, the local 
context in which drugs are used confers variable social and physical risks (including stigma and 
discrimination, social disadvantage, violence, and other harms) [49]. The variability of risk conferred 
in local environments of drug use complicates the potential and possible effects of evidence 
generated by particular methods as it is mobilised into policy. Features of the ‘risk environment’ are 
“ethically significant considerations” that ought to be taken into account when assessing the 
appropriateness and usefulness of particular research methods [49]. To date, wastewater analysis 
studies have had little ethical oversight. Wastewater analysis studies generally do not require 
approvals by human research ethics committees, or are considered to be ‘low-risk’ [40]. Ethical 
concerns have been raised about the use of wastewater analysis approaches in the context of 
monitoring a largely hidden and illegal practice like drug use, especially given that the informed 
consent of individuals is not required for this kind of research [2, 3]. These concerns have led to the 
development of ethical guidelines for undertaking wastewater analysis [3, 40] with the aim of 
fostering ethical practice across this new and burgeoning field of inquiry. An important ethical 
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dimension of wastewater analysis is the potential impact on groups of people, and this is not well 
captured in conventional frameworks governing ethical research with humans, which focus on 
individuals. For example, a number of studies have used wastewater analysis in small catchment 
areas such as schools [50, 51], prisons [52-54], and during short term events such as music festivals 
[55]. However, the recently published ethical guidelines note that there may be risks associated with 
conducting site-specific studies in settings such as schools, prisons and workplaces [40]. It has been 
suggested that site-specific studies can be unethical because data may be used to justify the 
introduction of punitive anti-drug strategies by prison authorities, unfair working conditions, and 
increase stigmatisation of targeted groups, inadvertently causing harm to participants who did not 
provide consent [40]. Indeed, these are not hypothetical concerns. In Australia, it has been 
suggested that sewage would be tested to identify specific geographic areas of high-drug use in 
order to implement a targeted strategy of drug testing welfare recipients in Australia [56].  
 
While it has been suggested that wastewater analysis ought not raise ethical concerns when used to 
monitor illicit drug use in large populations [41], our own research has demonstrated that these 
methods are not simply neutral ways of describing drug use realities and have a range of potentially 
deleterious political effects [13]. Claims that wastewater analysis approaches are ‘more accurate’ 
than self-report survey methods tend to carry weight because illicit drug use is a largely hidden and 
stigmatised practice, and because people who use drugs are already regarded as untrustworthy, 
unreliable and undeserving of a meaningful voice in research and drug policy decision-making [13]. 
Wastewater analysis approaches tend to foster an image of people who use drugs as lacking in 
knowledge (unable to ‘accurately’ report on their own drug use) and reinforces an impression of 
people who use drugs as criminal and in need of surveillance, thus reproducing the stigma  
perpetuated in popular discourse about drugs [13]. In the context of illicit drug epidemiology, the 
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more ‘scientific’, ‘direct’ and ‘accurate’ methods of wastewater analysis operate as a means of truth-
detection, revealing ‘tell-tale’ signs of otherwise hidden and illicit practices and populations [13].  
 
It has been suggested that having access to the kind of ‘objective’ and ‘accurate’ data generated by 
wastewater analysis will make a difference to drug policy decision-making and planning, and allow 
governments to be more responsive to changing needs [3, 4, 29]. However, such a view relies on a 
range of problematic assumptions about how drugs are understood as a policy problem and how 
evidence is mobilised in policy decision-making [13]. While other epidemiological methods can 
provide information about patterns of use, routes of administration, and demographic 
characteristics of people who use drugs, wastewater analysis approaches cannot provide data about 
specific drug use practices or harms [13]. Reporting of wastewater analysis necessarily emphasises 
drug use per se (and not drug related harms) as a measure of a ‘drug problem’ in a community and 
homogenises drug consumption within that specific geographic location [13]. The erasure of the 
contextual aspects of drug use is a weakness of any evidence provided by wastewater analysis, as it 
cannot include any information on the specific, socially situated and contingent practices associated 
with drug-related risk and harm [57, 58]. Mobilising evidence generated through wastewater 
analysis approaches shifts the focus of drug policy discussion from harm reduction (where the 
overarching goal is to reduce the harms associated with drug use without necessarily reducing use 
per se) to a more narrow and punitive goal of reducing population drug use per se, primarily 
informing demand reduction and supply reduction strategies. The persistent focus on drug use 
prevalence as the primary outcome measure used to assess drug policy has been called into 
question by leading drug policy scholars, as it belies the complexity of patterns of use (not all drug 
consumption is associated with harm; and even as prevalence decreases, drug-related harms may 
increase amongst some groups or in some places) [59-61]. Amidst calls to revise the range of 
indicators used to assess drug policy and more meaningfully evaluate “so-called real-world 
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outcomes of relevance to communities” by using measures which better discriminate between 
“problematic and non-problematic forms of drug use” [62], the narrow focus of wastewater analysis 
on measuring prevalence is arguably antiquated. While wastewater analysis might be a useful tool 
for providing information about the size or nature of drug markets in particular spatial locations over 
time, used as a measure of per capita population consumption these data have the potential to skew 
the kinds of policy questions which can be asked and the range of responses deemed appropriate by 
shifting the focus from drug-related harms to the mere use of drugs as evidenced by metabolic 
residues [13, 62].  
 
So long as the emphasis remains on generating evidence of illicit drug use per se, and not patterns of 
use or harms, the extent to which data generated via wastewater analysis can meaningfully inform 
harm reduction, treatment or health service planning is marginal. Even in early discussions about the 
potential of wastewater analysis approaches for illicit drug epidemiology it was acknowledged that 
“no single measure provides a full picture of the drug situation” [2]. However, the promise of 
technoscientific innovation, claims to ‘accuracy’ and ‘objectivity’, flexibility, timeliness and cost-
savings might mean that wastewater analysis measures are increasingly privileged (and funded) over 
and above other established epidemiological methods. Ensuring that wastewater analysis 
approaches are ethically and carefully integrated to complement established methods of drug 
epidemiology, rather than simply replacing them, is important. While “research in this field is 
progressing very fast” [4], staying alert to both the potential promise and pitfalls of these 
approaches as they are mobilised in drug policy discussions and decision-making will be crucial in the 
coming years. Without comprehensive information about the social, relational and contextual 
aspects of drug harms, effective drug policy will not be possible.  
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